Objective: Insulin-like growth factor I (IGF-1) stimulates cardiac growth and contraction, but resistance to its action has been reported in diabetes. This study was to determine if IGF-1-induced cardiac contractile action is altered in rats genetically predisposed to diabetes. Method: Ventricular myocytes were isolated from spontaneously biobreeding diabetes-prone (BB / DP) rats and their diabetes-resistant littermates (BB / DR). Mechanical properties were evaluated in cardiomyocytes using a video-based edge-detection system. Myocytes were electrically stimulated at 0.5 Hz. Contractile properties analyzed included peak shortening (PS), time-to-PS (TPS) and time-to-90% (10 -10 M) caused a dose-dependent increase in PS in myocytes from BB / DR but not BB / DP rats. The increase of PS was blunted by IGF-1 antagonist H-1356, phosphatidylinositol-3 (PI-3) kinase inhibitor wortmannin, but not tyrosine kinase inhibitor genistein. None of these agents affected responses to IGF-1 in BB / DP myocytes. Interestingly, IGF-1 elicited a comparable dose-dependent increase in 21 Ca transients in myocytes from both BB / DR and BB / DP rats. Conclusion: These results suggest that the attenuation of IGF-1-induced cardiac contractile response in chemically-induced diabetes also exists in diabetes of genetic origin, possibly due to mechanisms involving 21 PI-3 kinase and intracellular Ca sensitivity.
Introduction
ated with diabetic cardiomyopathy and is characterized by prolonged contraction duration, reduced force and deClinical and experimental evidence has indicated that creased compliance [5, 6] . The etiology of diabetic carthere is an increased cardiovascular mortality in diabetes diomyopathy is complex and may involve metabolic mellitus, both insulin-dependent and non-insulin dependerangements, decreased autonomic function, and abnordent. The mechanisms behind this high incidence remain malities in various hormones or proteins that regulate 21 largely obscure but may be associated with macro / microintracellular ion homeostasis, particular Ca [7] . Recentangiopathy, autonomic nephropathy and other factors ly, focus has been geared towards impaired insulin senleading to structural, metabolic or functional alterations of sitivity and glucose metabolism in the pathogenesis of the heart [1] [2] [3] . A specific form of cardiac muscle disease diabetic cardiomyopathy. Elevated glucose may directly during development of diabetes, namely diabetic carcontribute to the development of diabetic cardiomyopathy, diomyopathy, has also been recognized as an independent which can be protected by insulin sensitizing agents such causal factor for the enhanced mortality and morbidity in as thiazolidinediones and metformin [6, 8, 9] . These obdiabetes [4, 5] . Impaired myocardial contraction has been servations suggest a link between insulin sensitivity, shown to be the most prominent mechanical defect associglucose control and diabetic cardiomyopathy. Insulin-like growth factor I (IGF-1) is very similar to insulin in structure and cellular action and can be used as a the BB / DP rats. Blood glucose levels were measured replacement for insulin to control blood glucose in diaweekly using a glucose monitor (Accu-ChekII, model 792, betes, especially when there is insulin resistance. IGF-1 is Boehringer Mannheim Diagnostics, Indianapolis, IN, expressed and synthesized by various cell types and exerts USA). The active life of the Linplant was approximately its actions, such as enhancing cardiac growth and myocar-40 days, thereby eliminating the need for daily insulin dial contraction, in a paracrine / autocrine fashion. Alinjection. Re-implantation was performed when blood though long-term administration of IGF-1 can be associglucose levels exceeded 20 mM. The animals were sacated with cardiac hypertrophy and other cardiovascular rificed at 1 year of age. complications, IGF-1 has been shown to improve hemodynamics, myocardial function, energy metabolism and 2.2. Glucose tolerance test clinical status. We recently observed resistance to IGF-1 in myocardial contraction in streptozotocin (STZ)-induced Both BB / DR and BB / DP rats were fasted for 12 h and diabetes [10] . An altered cardiac IGF-1 / IGF-1 receptor then given an intraperitoneal (i.p.) injection of glucose (2 level has also been reported in diabetic patients and g / kg body wt.). Blood samples were drawn from the tail experimental animals, suggesting a role for IGF-1 in 15 min and immediately before the glucose challenge and diabetic cardiomyopathy [11, 12] .
15, 60 and 120 min thereafter. Serum glucose levels were The aim of the present investigation was to examine if determined using the Accu-Chek II glucose analyzer changes of IGF-1-induced cardiac contractile function also described above. persist in rats genetically predisposed to diabetes. The spontaneously diabetic BB Wistar rat was used as the 2.3. Cell isolation procedures model, which displays a diabetic syndrome, consisting of hypoinsulinemia, hyperglycemia and glycosuria. It is a Single ventricular myocytes were enzymatically isolated result of cell-mediated autoimmune destruction of pan- [10] . Briefly, hearts were rapidly removed and perfused (at creatic b-cells, a process that leads to insulin deficiency 378C) with Krebs-Henseleit bicarbonate (KHB) buffer and subsequently an increase in blood glucose and free containing (in mM): 118 NaCl, 4. myocardium, including loss of myofilaments, disruption of nally Ca -free KHB buffer for 2-3 min until spontaneous mitochondria, dilation of sarcoplasmic reticulum, decontractions ceased. This was followed by a 20-min 21 pressed myocardial contractility, rate of ventricular relaxaperfusion with Ca -free KHB containing 223 U / ml 21 tion and sarcoplasmic reticulum Ca [13] [14] [15] [16] . These collagenase (Worthington Biochemical, Freehold, NJ, effects are somewhat similar to those reported in USA) and 0.1 mg / ml hyaluronidase (Sigma, St. Louis, chemically-induced diabetic hearts [5, 6, 10] .
MO, USA). After perfusion, ventricles were removed and minced, under sterile conditions, and incubated with the above enzymatic solution for 3-5 min. The cells were 2. Methods further digested with 0.02 mg / ml trypsin (Sigma) before being filtered through a nylon mesh (300 mm) and sub-2. assessed using a SOFTEDGE video-based edge-detection inhibitors wortmannin (100 mM) or genistein (50 mM) for system (IonOptix, Milton, MA, USA) [10] . In brief, cells 15 min prior to exposure of IGF-1. These agents were also were placed in a Warner chamber mounted on the stage of present in the Hepes contractile buffer during respective 21 an inverted microscope (Olympus, X-70) and superfused experiments. The effect of elevated extracellular Ca on (|1 ml / min at 378C) with a buffer containing (in mM): myocyte shortening was evaluated with an increase of 1 21 131 NaCl, 4 KCl, 1 CaCl , 1 MgCl , 10 glucose, 10 Hepes mM Ca . Data from this laboratory suggested that there is 2 2 21 (pH 7.4). The cells were field stimulated with supraa linear relationship of extracellular Ca and shortening 21 threshold voltage at a frequency of 0.5 Hz and 3 ms when Ca is below 4 mM, whereas a saturated response duration, using a pair of platinum wires placed on opposite is usually achieved between 3.5 and 4 mM. Myocytes with sides of the chamber connected to a FHC stimulator rundown .10% in peak twitch amplitude over the first 5 (Brunswick, NE, USA). The myocyte being studied was min were not studied further. displayed on the computer monitor using an IonOptix MyoCam camera. The SOFTEDGE software (IonOptix) was 2.7. Statistical analyses used to capture changes in cell length during shortening and relengthening.
For each experimental series, data are presented as mean6S.E.M. Statistical significance (P,0.05 or P,0.01) 2.5. Intracellular fluorescence measurement for each variable was estimated by analysis of variance (ANOVA) or t-test, where appropriate (Systat, Evanston, A separate cohort of myocytes was loaded with fura-2 / IL, USA). AM (0.5 mM) for 10 min and fluorescence measurements were recorded with a dual-excitation fluorescence photomultiplier system (Ionoptix) as previously described [10] .
3. Results Myocytes were placed on an Olympus X-70 inverted microscope equipped with a heated (378C) chamber and 3.1. General features of BB /DR and BB /DP rats imaged through a Fluor340 oil objective. Cells were exposed to light emitted by a 75-W lamp and passed Prolonged spontaneously diabetic state significantly through either a 360-or a 380-nm filter (bandwidths were slowed down body weight gain and elevated plasma 615 nm), while being stimulated to contract at 0.5 Hz.
glucose levels in BB / DP rats compared to the BB / DR Fluorescence emissions were detected between 480 and littermates. Although the absolute heart weight was less 520 nm by a photomultiplier tube after first illuminating than the BB / DR controls, the heart / body weight ratio was cells at 360 nm for 0.5 s then at 380 nm for the duration of significantly greater in BB / DP rats. Diabetic animals also the recording protocol (333 Hz sampling rate). The 360 nm exhibited hepatomegaly and renal hypertrophy (Table 1) . excitation scan was repeated at the end of the protocol and Under continuous Linplant insulin treatment, the 12-h fasting plasma glucose levels in BB / DP rats were still 2.6. Experimental protocol significantly higher than the levels of BB / DR group. Following the intraperitoneal glucose challenge, the plasMyocytes (either fura-2 loaded or non-loaded) were ma glucose levels in BB / DR rats returned to the baseline allowed to contract at a stimulation frequency of 0.5 Hz value after 120 min. However, the post-challenge hyover 10 min to ensure steady state before superfusing with perglycemia was considerably greater in BB / DP rats at 15, different concentrations of IGF-1 (recombinant human 60 and 120 min compared to those of from the non-
IGF-1, 10 -10 M) for 5 min. Cells were then washed diabetic rats (Fig. 1) . These glucose tolerance tests were with normal contractile buffer for 5 min. In some expericonducted at about 11 months of age and have clearly ments, myocytes were pre-incubated with IGF-1 receptor indicated glucose intolerance in these genetically predisantagonist H-1356 (20 mg / ml for 4 h), protein kinase posed diabetic rats. The average resting cell length (CL) of ventricular intracellular Ca levels have also been reported in myocytes used in this study was 11265 and 12364 mm in chemically-induced diabetes [17, 18] . Interestingly, acute BB / DR and BB / DP group, respectively (33 cells / group).
IGF-1 exposure caused a concentration-dependent increase 21 The peak shortening (PS, normalized to CL) in response to in intracellular Ca (DFFI5peak FFI2baseline FFI) in electrical stimuli in myocytes from BB / DR and BB / DP myocytes from both BB / DR and BB / DP animals ( Fig. 3) . hearts was 5.7360.35 and 7.4960.72%, respectively (P,
The threshold where IGF-1 exerted a significant increase in
0.05), indicating an enhanced myocyte contractile function Ca transient was between 10 and 10 M. DFFI in BB / DP rats. Consistent with the observation in STZachieved steady state at or before 5 min and cells reinduced diabetes [6, 10] , myocytes isolated from BB / DP covered partially following washout. Neither resting FFI rats exhibited significantly prolonged duration of shortnor the t value was affected by IGF-1 ( Table 3 ). The ening (TPS) and relengthening (TR ), compared to those disparate response of IGF-1 on myocyte shortening and 90 21 from BB / DR rats ( Table 2 ). Fig. 2A shows representative intracellular Ca in BB / DP myocytes suggests reduced 27 21 traces depicting the typical effect of IGF-1 (10 M) on myofibril responsiveness to intracellular Ca in BB cell shortening in myocytes isolated from BB / DR and diabetic hearts. BB / DP hearts. At the end of a 5-min exposure to this concentration of IGF-1, PS was increased by 24.3% in 3. the threshold was between 10 and 10 M (Fig. 2B) . ceptor mechanism(s) involved in the IGF-1-induced car- diac contractile response, myocyte shortening in response were studied in myocytes incubated with PI-3 inhibitor to IGF-1 was re-examined in the presence of IGF-1 wortmannin (100 mM) or tyrosine kinase inhibitor genisanalogue, H-1356 (Bachem Bioscience, King of Prussia, tein (50 mM). In these experiments the average resting CL PA, USA). This peptide inhibits the autophosphorylation of of myocytes used was 11964 and 12264 mm in the the IGF-1 receptor by IGF-1 and therefore decreases its BB / DR and BB / DP groups, respectively. The PS in activity [19] . To block the action of IGF-1, H-1356 (20 response to electrical stimulation was 5.460.4% (BB / DR) mg / ml) was pre-incubated with the cardiomyocytes for 4 h and 6.060.5% (BB / DP) (16 cells / group, P.0.05). As and was presented throughout the experimental protocol.
shown in Fig. 4B , the IGF-1-induced potentiation in cell Not surprisingly, the IGF-1-induced positive response in shortening in myocytes from BB / DR hearts was greatly cell shortening in BB / DR myocytes was completely attenuated by wortmannin but not genistein. The IGF-1 blunted (even with slight inhibition) by H-1356 (Fig. 4A) .
induced contractile profile in BB / DP hearts was not These results indicated the IGF-1-induced cardiac contracaffected with the presence of kinase antagonists. Neither tile response is likely to be mediated through the IGF-1 wortmannin nor genistein alone had any effect on myocyte receptor specifically.
shortening.
Effect of IGF-1 on myocyte shortening in the 3.7. Effect of insulin, norepinephrine, KCl and increase

presence of wortmanin and genistein of extracellular Ca on myocyte shortening
To elucidate the mechanism of action involved in IGFFor comparison, the contractile responses of insulin (100 1-induced cardiac contractile response, inhibitors of differnM), norepinephrine (NE, 1 mM) and KCl (30 mM) were ent pathways were added to cardiac myocytes before examined in myocytes from both BB / DR and BB / DP incubation with IGF-1. The potential roles of groups (Fig. 5) . Myocytes from BB / DP group exhibited phosphatidylinositol-3 (PI-3) kinase or tyrosine kinase significantly enhanced contractile response to insulin, activation in mediating IGF-1-induced cardiac response comparable response to KCl and reduced response to NE, extracellular Ca concentration by 1 mM increased the myocyte shortening by 69% in BB / DR myocytes. How-IGF-1 promotes cardiac growth, improves cardiac conever, a similar maneuver only increased the myocyte tractility, cardiac output, stroke volume, and ejection shortening by 10% in myocytes isolated from BB / DP rat fraction. It also facilitates glucose metabolism, lowers hearts (Fig. 5) . These data indicated a depressed a-adreninsulin level, increases insulin sensitivity, and improves the ergic action and altered insulin responsiveness as well as lipid profile, suggesting both a physiological role and a 21 myofibril Ca sensitivity in heart from spontaneously therapeutic potential of the hormone. IGF-1 and its binding diabetic rats, which may underscore the differential IGF-1-proteins have been considered as markers for the presence induced contractile response between the two groups.
of certain cardiac abnormalities [12] . Altered responsive- ness to the action of IGF-1 has been shown in diabetes, One of the important findings of this study is the hypertension and obesity [10, [20] [21] [22] , indicating a relationprolonged duration of myocyte shortening and relengthen- 21 ship between IGF-1 and certain cardiac disorders [23] . The ing, associated with reduced baseline intracellular Ca results from the current investigation revealed that IGF-1 level (FFI) in genetically predisposed diabetes. Prolonged increased myocyte contraction in cells from BB / DR but duration of cardiac contraction and relaxation has been not BB / DP rat hearts. The IGF-1-induced increase of cell documented in chemically-induced diabetes [5, 6] , and in shortening was blunted by its receptor antagonist H-1356.
working heart of genetic diabetes [16] . Several factors Furthermore, the positive response was blocked by the have been suggested to contribute to such defects, includ-PI-3 kinase inhibitor wortmannin but not the tyrosine ing depressed activity of sarco(endo)plasmic ATPase kinase inhibitor genistein. Interestingly, IGF-1 increased (SERCA) [24] and Na-Ca exchange [25] , as well as shift 21 intracellular Ca transients in both BB / DR and BB / DP of contractile protein myosin isoforms (from fast type V to 1 myocytes. Therefore, the present study further confirmed slow type V ) [26] . The reduction of resting FFI observed 3 the notion of attenuated IGF-1 responsiveness in the in this study is also consistent with the reports from the setting of genetically predisposed diabetes.
chemically-induced diabetes [18] . Although there is still induced cardiac response is likely to be mediated through the IGF-1 receptor, instead of insulin receptor. The direct evidence from insulin showed an augmented responsiveness in spontaneous diabetes, opposite to that exerted by IGF-1 (Fig. 5) . The fact that H-1356 inhibited cardiac contraction may suggest a role for endogenous IGF-1 production by cardiac myocytes in determining myocardial contractile response. Circulating IGF-1 may act as an endogenous regulator of myocardial contractility. The rapid onset, the long duration of effect, and the relatively modest magnitude of its action compared with other endogenous substances suggest that if IGF-1 has any acute cardioregulatory role, it may contribute to the modulation of the inotropic responsiveness of the myocardium over a time frame of minutes to hours, sensitizing the myofila- chemically-induced diabetes [10] , in which IGF-1 failed to baseline, [, P,0.05 vs. BB / DR group. 21 elicit any response in intracellular Ca transients in cardiac myocytes from diabetic rats. This apparent dissome controversy regarding the underlying mechanisms, crepancy in cardiac excitation-contraction (E-C) coupling 21 the depressed resting Ca level in diabetes is believed to may be largely due to distinct subcellular mechanisms, be associated, at least in part, with the reduced sarcoplassuch as SR function, contractile proteins and certain signal 21 21 mic Ca stores, transmembrane Ca uptake and Na-H pathways, between the genetically predisposed and the exchange due to intracellular pH change [17, 18] .
chemically-induced diabetic models. However, little direct IGF-1 enhances myocardial contractility [10, 20, 27] and evidence is available at this point and further study is is considered as a more important cardiac hormone than warranted to better explore such discrepancy in E-C insulin. Although the mechanisms of action involved in coupling.
IGF-1-induced myocardial function have not yet been fully
The reduced contractile response of cardiac myocyte to 21 studied, several potential mechanisms may be worthy of increase of intracellular Ca observed after IGF-1 expoconsideration including IGF-1-induced IP accumulation, sure in BB / DP hearts may reflect potential alteration in the 3 21 which leads to increases in intracellular Ca concenintracellular signaling pathway(s) that can be activated by tration [28] , and IGF-1-induced increase in intracellular the IGF-1-receptor complex in diabetes. The IGF-1 sig- 21 Ca sensitivity, which results in an enhanced contractile naling cascades are initiated with binding of IGF-1 to its responsiveness [29] . In the present study, IGF-1 increased membrane receptors, which are associated with Crk, Shc myocyte shortening in myocytes from BB / DR but not and insulin substrate-1 (IRS-1). Phosphorylation of Crk, BB / DP rats. This disparate pattern was not associated with Shc and IRS-1 leads to the activation of Ras, and the traction may be abrogated by a reduced intracellular Ca kinase [23, 31] . PI-3 kinase is essential for the transduction sensitivity in BB / DP myocytes, which has been reported of metabolic growth and functional effects of IGF-1 and in diabetes [30] . This was supported also by the observainsulin, including stimulation of glucose transport [32, 33] , tion of a reduced responsiveness to increase of excellular antilipolysis [33] , protein and glycogen synthesis [34] , 21 Ca (Fig. 5) . (2) The diabetes-associated alteration(s) of inhibition of apoptosis [35] , and more recently, IGF-1 certain IGF-1 receptor-mediated signaling pathways, such mediated cardiomyocyte contractility [29] . Activation of as protein kinases, may also contribute to changes in phospholipase C [36] and rapid elevation of intracellular IGF-1-induced cardiac responses, although there is little inositol phosphate levels [28] have been also reported in evidence available at this time.
cardiac cells. Although the linkage of above mentioned The positive cardiac contractile effect of IGF-1 was signaling cascades to the altered modulation of cardiac blocked by IGF-1 antagonist H-1356, which itself deprecontractility of IGF-1 under diabetes is not clear, the sses cardiac contraction. This data suggested that IGF-1-present study strongly suggested the involvement of PI-3 
